123 related articles for article (PubMed ID: 29748789)
1. The polymorphism rs2480258 within CYP2E1 is associated with different rates of acrylamide metabolism in vivo in humans.
Pellè L; Carlsson H; Cipollini M; Bonotti A; Foddis R; Cristaudo A; Romei C; Elisei R; Gemignani F; Törnqvist M; Landi S
Arch Toxicol; 2018 Jun; 92(6):2137-2140. PubMed ID: 29748789
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers of human exposure to acrylamide and relation to polymorphisms in metabolizing genes.
Duale N; Bjellaas T; Alexander J; Becher G; Haugen M; Paulsen JE; Frandsen H; Olesen PT; Brunborg G
Toxicol Sci; 2009 Mar; 108(1):90-9. PubMed ID: 19131562
[TBL] [Abstract][Full Text] [Related]
3. Role of CYP2E1 in the epoxidation of acrylamide to glycidamide and formation of DNA and hemoglobin adducts.
Ghanayem BI; McDaniel LP; Churchwell MI; Twaddle NC; Snyder R; Fennell TR; Doerge DR
Toxicol Sci; 2005 Dec; 88(2):311-8. PubMed ID: 16141435
[TBL] [Abstract][Full Text] [Related]
4. The modifying effect of CYP2E1, GST, and mEH genotypes on the formation of hemoglobin adducts of acrylamide and glycidamide in workers exposed to acrylamide.
Huang YF; Chiang SY; Liou SH; Chen ML; Chen MF; Uang SN; Wu KY
Toxicol Lett; 2012 Nov; 215(2):92-9. PubMed ID: 23069881
[TBL] [Abstract][Full Text] [Related]
5. Human CYP2E1 mediates the formation of glycidamide from acrylamide.
Settels E; Bernauer U; Palavinskas R; Klaffke HS; Gundert-Remy U; Appel KE
Arch Toxicol; 2008 Oct; 82(10):717-27. PubMed ID: 18418580
[TBL] [Abstract][Full Text] [Related]
6. Cord blood acrylamide levels and birth size, and interactions with genetic variants in acrylamide-metabolising genes.
Hogervorst J; Vesper HW; Madhloum N; Gyselaers W; Nawrot T
Environ Health; 2021 Apr; 20(1):35. PubMed ID: 33794901
[TBL] [Abstract][Full Text] [Related]
7. In vivo role of cytochrome P450 2E1 and glutathione-S-transferase activity for acrylamide toxicokinetics in humans.
Doroshyenko O; Fuhr U; Kunz D; Frank D; Kinzig M; Jetter A; Reith Y; Lazar A; Taubert D; Kirchheiner J; Baum M; Eisenbrand G; Berger FI; Bertow D; Berkessel A; Sörgel F; Schömig E; Tomalik-Scharte D
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):433-43. PubMed ID: 19190172
[TBL] [Abstract][Full Text] [Related]
8. Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma.
Pellé L; Cipollini M; Tremmel R; Romei C; Figlioli G; Gemignani F; Melaiu O; De Santi C; Barone E; Elisei R; Seiser E; Innocenti F; Zanger UM; Landi S
Arch Toxicol; 2016 Dec; 90(12):3099-3109. PubMed ID: 26783003
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of Acrylamide: Interindividual and Interspecies Differences as Well as the Application as Biomarkers.
Li D; Wang P; Liu Y; Hu X; Chen F
Curr Drug Metab; 2016; 17(4):317-26. PubMed ID: 26467066
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of acrylamide to glycidamide and their cytotoxicity in isolated rat hepatocytes: protective effects of GSH precursors.
Kurebayashi H; Ohno Y
Arch Toxicol; 2006 Dec; 80(12):820-8. PubMed ID: 16699760
[TBL] [Abstract][Full Text] [Related]
11. Genotoxicity of acrylamide in vitro: Acrylamide is not metabolically activated in standard in vitro systems.
Koyama N; Yasui M; Oda Y; Suzuki S; Satoh T; Suzuki T; Matsuda T; Masuda S; Kinae N; Honma M
Environ Mol Mutagen; 2011 Jan; 52(1):11-9. PubMed ID: 20209648
[TBL] [Abstract][Full Text] [Related]
12. The role of human cytochrome P450 enzymes in metabolism of acrylamide in vitro.
Kraus D; Rokitta D; Fuhr U; Tomalik-Scharte D
Toxicol Mech Methods; 2013 Jun; 23(5):346-51. PubMed ID: 23256458
[TBL] [Abstract][Full Text] [Related]
13. Biomarker analysis of hemoglobin adducts of acrylamide and glycidamide enantiomers for mid-term internal exposure assessment by isotope dilution ultra-high performance liquid chromatography tandem mass spectrometry.
Zhang Y; Wang Q; Zhang G; Jia W; Ren Y; Wu Y
Talanta; 2018 Feb; 178():825-833. PubMed ID: 29136901
[TBL] [Abstract][Full Text] [Related]
14. In vitro studies of the influence of glutathione transferases and epoxide hydrolase on the detoxification of acrylamide and glycidamide in blood.
Paulsson B; Rannug A; Henderson AP; Golding BT; Törnqvist M; Warholm M
Mutat Res; 2005 Feb; 580(1-2):53-9. PubMed ID: 15668107
[TBL] [Abstract][Full Text] [Related]
15. Association of CYP2E1, GST and mEH genetic polymorphisms with urinary acrylamide metabolites in workers exposed to acrylamide.
Huang YF; Chen ML; Liou SH; Chen MF; Uang SN; Wu KY
Toxicol Lett; 2011 Jun; 203(2):118-26. PubMed ID: 21402133
[TBL] [Abstract][Full Text] [Related]
16. Absence of acrylamide-induced genotoxicity in CYP2E1-null mice: evidence consistent with a glycidamide-mediated effect.
Ghanayem BI; Witt KL; Kissling GE; Tice RR; Recio L
Mutat Res; 2005 Oct; 578(1-2):284-97. PubMed ID: 15982677
[TBL] [Abstract][Full Text] [Related]
17. In vivo doses of acrylamide and glycidamide in humans after intake of acrylamide-rich food.
Vikström AC; Abramsson-Zetterberg L; Naruszewicz M; Athanassiadis I; Granath FN; Törnqvist MÅ
Toxicol Sci; 2011 Jan; 119(1):41-9. PubMed ID: 20952504
[TBL] [Abstract][Full Text] [Related]
18. Mouse spermatocytes express CYP2E1 and respond to acrylamide exposure.
Nixon BJ; Katen AL; Stanger SJ; Schjenken JE; Nixon B; Roman SD
PLoS One; 2014; 9(5):e94904. PubMed ID: 24788432
[TBL] [Abstract][Full Text] [Related]
19. Comparison of estimated dietary intake of acrylamide with hemoglobin adducts of acrylamide and glycidamide.
Bjellaas T; Olesen PT; Frandsen H; Haugen M; Stølen LH; Paulsen JE; Alexander J; Lundanes E; Becher G
Toxicol Sci; 2007 Jul; 98(1):110-7. PubMed ID: 17449897
[TBL] [Abstract][Full Text] [Related]
20. Dietary determinants for Hb-acrylamide and Hb-glycidamide adducts in Danish non-smoking women.
Outzen M; Egeberg R; Dragsted L; Christensen J; Olesen PT; Frandsen H; Overvad K; Tjønneland A; Olsen A
Br J Nutr; 2011 May; 105(9):1381-7. PubMed ID: 21272397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
